期刊文献+

实时影像虚拟导航系统在肝癌微创治疗中的初步应用 被引量:18

Real-time virtual navigation system for percutaneous ablation of sonographically unidentified hepatic malignacies
原文传递
导出
摘要 目的应用实时影像融合虚拟导航技术对常规超声显示不佳的肝癌病灶行经皮肿瘤微创治疗,明确此影像技术的安全性、可行性及临床应用价值。方法15例患者共22个肝癌病灶接受虚拟导航引导卞经皮消融术,并于术后1月内经增强CT/MR评定消融效果。结果20个病灶完全消融,2个病灶有局部残留。未出现与治疗相关的并发症。结论实时影像虚拟导航系统能精确定位病灶,引导穿刺和监控治疗,特别对常规超声不显示的肝癌病灶,虚拟导航技术更显示出优越性。 Objective To evaluate the safety, feasibility and clinical value of real-time navigation system with CT/MR and sonographic images for percutaneous ablation of hepatic malignancies poorly defined on conventional ultrasonography. Methods Fifteen patients with 22 hepatic malignant lesions underwent percutaneous ablation guided by virtual navigation system with ultrasonography. Treatment response was assessed by the contrast CT/MR followed up one month after procedures. Results Complete tumor necrosis was achieved in 20 lesions,but 2 lesions showed residual tumor in the ablation zone. No treatment associated complications were found. Conclusions The application of virtual navigation system is of clinical value in localization of lesions, guidance of biopsy and assessment of the interventional therapy in patient with hepatic malignancies, particularly for those with poorly identified lesions by conventional ultrasonography.
出处 《中华超声影像学杂志》 CSCD 北大核心 2009年第9期768-771,共4页 Chinese Journal of Ultrasonography
关键词 超声检查 介入性 肝肿瘤 导管消融术 乙醇/治疗应用 Ultrasonography, interventional Liver Neoplasms Catheter ablation Ethanol/therapeutic use
  • 相关文献

参考文献8

  • 1Shiina S, Teratani T,Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology, 2005,129 : 122-130.
  • 2Aramaki M, Kawano K, Ohno T, et al. Microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology, 2004,51 : 1784-1787.
  • 3Iuchi H, Horiike N, Masumoto T, et al. Specially designed needleguided for intercostals puncture of hepatocellular carcinoma seen on computed tomography and not visualized on uhrasonography. Hepatol Res,2003,25:319-328.
  • 4Hertzberg BS, Kliewer MA, Bowie JD, et al. Physician training requirements in sonography:how many cases are needed for competence? Am J Roentgenol, 2000, 174 :1221-1227.
  • 5Maruyama H, Kobayashi S, Yoshizumi H, et al. Application of percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatoeellular carcinoma using microbubble contrast agent. Clin Radiol, 2007,62 : 668-675.
  • 6percutaneous ultrasound-guided treatment for ultrasonically invisible hypervascular hepatocellular carcinoma using microbubble contrast agent. Clin Radiol, 2007,62 : 668-675.
  • 7刘广健,吕明德,谢晓燕,周旭辉,徐辉雄,匡铭,徐作峰,郑艳玲,梁瑾瑜,黄蓓.实时虚拟导航系统引导消融治疗肝癌[J].中华超声影像学杂志,2006,15(10):758-760. 被引量:15
  • 8Lin SM, Lin CJ, Lin CC, et al. Radiofrequency ablation improves prognosis compared withethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology, 2004,127 : 1714-1723.

二级参考文献9

  • 1Dodd GD 3rd,Soulen MC,Kane RA,et al.Minimally invasive treatment of malignant hepatic tumors:at the threshold of major breakthrough.Radiographics,2000,20:9-27.
  • 2Lu MD,Chen JW,Xie XY,et al.Hepatocellular carcinoma:US-guided percutaneous microwave coagulation therapy.Radiology,2001,221:167-172.
  • 3Kim SK,Lim HK,Kim YH,et al.Hepatocellular carcinoma treated with radio-frequency ablation:spectrum of imaging findings.Radiographics,2003,23:107-121.
  • 4Dromain C,de Baere T,Elias D,et al.Hepatic tumors treated with percutaneous radio-frequency ablation:CT and MR imaging follow-up.Radiology,2002,223:255-262.
  • 5Goldberg S,Grassi C,Cardella J,et al.Image-guided tumor ablation:standardization of terminology and reporting criteria.Radiology,2005,235:728-739.
  • 6Goldberg S,Gazelle G,Compton C,et al.Treatment of intrahepatic malignancy with radiofrequency ablation:radiologic-pathologic correlation.Cancer,2000,88:2452-2463.
  • 7Choi D,Lim HK,Kim SH,et al.Hepatocellular carcinoma treated with percutaneous radio-frequency ablation:usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.Radiology,2000,217:558-563.
  • 8Choi D,Lim HK,Lee WJ,et al.Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma utility of gray scale harmonic ultrasonography with a microbubble contrast agent.J Ultrasound Med,2003,22:1163-1172.
  • 9Solbiati L,Tonolini M,Cova L.Monitoring RF ablation.Eur Radiol,2004,14(Suppl 8):34-42.

共引文献14

同被引文献280

引证文献18

二级引证文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部